Literature DB >> 20531432

Stroke: hyperlipidemia and cerebral small-vessel disease.

Jessica R L Warsch, Clinton B Wright.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20531432     DOI： 10.1038/nrneurol.2010.70

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Identification of genetic variants associated with response to statin therapy.

Authors:  Jessica L Mega; David A Morrow; Alison Brown; Christopher P Cannon; Marc S Sabatine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-10       Impact factor: 8.311

Review 2.  White matter changes in stroke patients. Relationship with stroke subtype and outcome.

Authors:  D Leys; E Englund; T Del Ser; D Inzitari; F Fazekas; N Bornstein; T Erkinjuntti; J V Bowler; L Pantoni; L Parnetti; J De Reuck; J Ferro; J Bogousslavsky
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

3.  Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Authors:  W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

4.  Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.

Authors:  Robin Lemmens; Astrid Görner; Maarten Schrooten; Vincent Thijs
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

5.  Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.

Authors:  Jordi Jimenez-Conde; Alessandro Biffi; Rosanna Rahman; Allison Kanakis; Christi Butler; Shruti Sonni; Efi Massasa; Lisa Cloonan; Aaron Gilson; Karen Capozzo; Lynelle Cortellini; Angel Ois; Elisa Cuadrado-Godia; Ana Rodriguez-Campello; Karen L Furie; Jaume Roquer; Jonathan Rosand; Natalia S Rost
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

6.  Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study.

Authors:  Tom Skyhøj Olsen; Rune Haubo Bojesen Christensen; Lars Peter Kammersgaard; Klaus Kaae Andersen
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

7.  Ischaemic stroke subtypes and associated risk factors: a French population based study.

Authors:  Y Bejot; M Caillier; D Ben Salem; G Couvreur; O Rouaud; G-V Osseby; J Durier; C Marie; T Moreau; M Giroud
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-06-27       Impact factor: 10.154

8.  Lipids in ischemic stroke subtypes.

Authors:  P Laloux; L Galanti; J Jamart
Journal:  Acta Neurol Belg       Date:  2004-03       Impact factor: 2.396

9.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

10.  Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study.

Authors:  Halina White; Bernadette Boden-Albala; Cuiling Wang; Mitchell S V Elkind; Tanja Rundek; Clinton B Wright; Ralph L Sacco
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690
  10 in total
  4 in total

Review 1.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

Review 2.  Hurdles to clear before clinical translation of ischemic postconditioning against stroke.

Authors:  Heng Zhao
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

3.  Clinical characterization of symptomatic microangiopathic brain lesions.

Authors:  Stefanie Leistner; Hans-Christian Koennecke; Jens P Dreier; Anne-Katrin Strempel; Markus Kathke; Alexandrina Nikolova; Peter Heuschman; Uwe Malzahn; Heinrich J Audebert; Bruno-Marcel Mackert
Journal:  Front Neurol       Date:  2011-09-22       Impact factor: 4.003

4.  Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study.

Authors:  Kok Pin Ng; Aloysius Ng; Pryseley Assam; Esther Heng; Nagaendran Kandiah
Journal:  Drugs R D       Date:  2014-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.